- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Bemcentinib.
Displaying page 1 of 1.
EudraCT Number: 2019-003806-28 | Sponsor Protocol Number: BGBC016 | Start Date*: 2023-04-26 | |||||||||||
Sponsor Name:BerGenBio ASA | |||||||||||||
Full Title: Phase 1b/2a safety and tolerability study of bemcentinib with pembrolizumab/carboplatin/pemetrexed in subjects with untreated advanced or metastatic non-squamous non-small cell lung cancer (NSCL... | |||||||||||||
Medical condition: untreated advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) without/with a STK11 mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) HU (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003609-32 | Sponsor Protocol Number: BGBC008/MK-3475PN-531 | Start Date*: 2018-08-24 | |||||||||||
Sponsor Name:BerGenBio ASA | |||||||||||||
Full Title: A Phase II Multi-Center Study of BGB324 in Combination with Pembrolizumab in Patients with Previously Treated Advanced Adenocarcinoma of the Lung. | |||||||||||||
Medical condition: Previously Treated Advanced Adenocarcinoma of the Lung | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003353-41 | Sponsor Protocol Number: 0627 | Start Date*: 2018-07-05 |
Sponsor Name:University of Leicester | ||
Full Title: Mesothelioma Stratified Therapy (MiST): A stratified multi-arm phase IIa clinical trial to enable accelerated evaluation of targeted therapies for relapsed malignant mesothelioma. | ||
Medical condition: Malignant Mesothelioma (MM) - pleural and peritoneal | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001736-95 | Sponsor Protocol Number: ACCORD-2-001,Sub002,003,006 | Start Date*: 2020-04-28 | |||||||||||
Sponsor Name:University Hospital Southampton NHS Foundation Trust | |||||||||||||
Full Title: ACCORD 2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID 19 in Hospitalised Patients | |||||||||||||
Medical condition: COVID 19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
